CD8A and neoplasm: Prior immunohistochemical studies [39,40] have demonstrated the ability of CD8 lymphocytes to interact with tumor cells, resulting in the production of interferons, which in turn triggered a series of antitumor responses, including cell cycle inhibition and the induction of macrophage tumoricidal activity.